Recordati SpA (RICFY)
14.96
+2.16
(+16.93%)
USD |
OTCM |
Jun 10, 16:00
Recordati EPS Diluted (Quarterly) : 0.2141 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2141 |
| December 31, 2025 | 0.1632 |
| September 30, 2025 | 0.154 |
| June 30, 2025 | 0.1233 |
| March 31, 2025 | 0.1573 |
| December 31, 2024 | 0.0997 |
| September 30, 2024 | 0.1483 |
| June 30, 2024 | 0.1311 |
| March 31, 2024 | 0.1604 |
| December 31, 2023 | 0.1089 |
| September 30, 2023 | 0.1001 |
| June 30, 2023 | 0.1347 |
| March 31, 2023 | 0.1591 |
| December 31, 2022 | 0.0864 |
| September 30, 2022 | 0.1085 |
| June 30, 2022 | 0.0697 |
| March 31, 2022 | 2.073 |
| December 31, 2021 | 1.961 |
| September 30, 2021 | 2.013 |
| June 30, 2021 | 2.701 |
| March 31, 2021 | 2.072 |
| December 31, 2020 | 1.846 |
| September 30, 2020 | 1.725 |
| June 30, 2020 | 1.806 |
| March 31, 2020 | 2.344 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.1525 |
| September 30, 2019 | 1.69 |
| June 30, 2019 | 1.766 |
| March 31, 2019 | 1.998 |
| December 31, 2018 | 1.629 |
| September 30, 2018 | 0.1024 |
| June 30, 2018 | 0.1105 |
| March 31, 2018 | 0.1272 |
| December 31, 2017 | 1.554 |
| September 30, 2017 | 0.103 |
| June 30, 2017 | 0.0917 |
| March 31, 2017 | 1.599 |
| December 31, 2016 | 1.134 |
| September 30, 2016 | 0.0797 |
| June 30, 2016 | 1.238 |
| March 31, 2016 | 0.0863 |
| December 31, 2015 | 0.0601 |
| September 30, 2015 | 0.0654 |
| June 30, 2015 | 0.0683 |
| March 31, 2015 | 0.0687 |
| December 31, 2014 | 0.055 |
| September 30, 2014 | 0.0653 |
| June 30, 2014 | 0.0656 |
| March 31, 2014 | 0.0692 |
| December 31, 2013 | 0.0519 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DiaSorin SpA | -- |
| AbbVie, Inc. | 0.3861 |
| Abeona Therapeutics, Inc. | -0.3016 |
| Ascentage Pharma Group International Co., Ltd. | -- |
| Aardvark Therapeutics, Inc. | -0.9896 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 179.07M |
| Revenue (Quarterly) | 834.65M |
| Total Expenses (Quarterly) | 655.58M |
| Enterprise Value | 14.46B |
| Gross Profit Margin (Quarterly) | 71.60% |
| Profit Margin (Quarterly) | 21.45% |
| Earnings Yield | 4.38% |
| Operating Earnings Yield | 7.00% |
| Normalized Earnings Yield | 4.684 |